UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Highly enhanced Raman scattering from coupled vertical silicon nanowire arrays

Applied physics letters, 2012-10, Vol.101 (17)

2012

Volltextzugriff (PDF)

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

British journal of cancer, 2008-04, Vol.98 (8), p.1327-1335

2008

Volltextzugriff (PDF)

NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy

Annals of oncology, 2014-06, Vol.25, p.ii105-ii105

2014

Volltextzugriff (PDF)

Nanowire dopant measurement using secondary ion mass spectrometry

Journal of applied physics, 2015-09, Vol.118 (11)

2015

Volltextzugriff (PDF)

PD-023 Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

Annals of oncology, 2016-06, Vol.27, p.ii110

2016

Volltextzugriff (PDF)

PD-023Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) plus or minus 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii110-ii110

2016

Volltextzugriff (PDF)

PD-023Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

Annals of oncology, 2016-06, Vol.27 (Suppl 2), p.ii110-ii110

2016

Volltextzugriff (PDF)

Abstract P4-12-29: Assessment of safety and activity in an expanded phase 1 study of MM-302, a HER2-targeted liposomal doxorubicin, in patients with advanced HER2-positive (HER2+) breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-12-29

2013

Volltextzugriff (PDF)

A randomized, double-blind phase II trial of exemestane with or without MM-121 in postmenopausal women with locally advanced or metastatic estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+), HER2-negative breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS112-TPS112

2011

Volltextzugriff (PDF)

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Nature (London), 2021-09, Vol.597 (7877), p.527-532

2021

Volltextzugriff (PDF)

Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency

PLoS genetics, 2023-10, Vol.19 (10), p.e1010952-e1010952

2023

Volltextzugriff (PDF)

Caffeine Effects on eGFR Dip in Patients Who Started SGLT2 Inhibitors: TH-PO1055

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.387-387

2023

Volltextzugriff (PDF)

Rare variant associations with plasma protein levels in the UK Biobank

Nature (London), 2023-10, Vol.622 (7982), p.339-347

2023

Volltextzugriff (PDF)

Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitor

Frontiers in cellular neuroscience, 2023-05, Vol.17, p.1175895

2023

Volltextzugriff (PDF)

Associations of Social Determinants of Health With SGLT2 Inhibitor Use in Kidney Transplant Recipients: A National Study: FR-PO814

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.546-547

2022

Volltextzugriff (PDF)

Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences

Nature genetics, 2024-09, Vol.56 (9), p.1832-1840

2024

Volltextzugriff (PDF)

Natural Approaches in Diabetes Management: A Review of Diet, Exercise, and Natural Products

Current pharmaceutical design, 2018-01, Vol.24 (1), p.84-98

2018

Volltextzugriff (PDF)

Very Early Administration of Progesterone for Acute Traumatic Brain Injury

The New England journal of medicine, 2014-12, Vol.371 (26), p.2457-2466

2014

Volltextzugriff (PDF)

Arterial stiffening following eccentric exercise-induced muscle damage

Journal of applied physiology (1985), 2010-10, Vol.109 (4), p.1102-1108

2010

Volltextzugriff (PDF)

Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity

Journal of applied physiology (1985), 2008-08, Vol.105 (2), p.427-432

2008

Volltextzugriff (PDF)

Composite Events Associated with Increased Expected Post-Transplant Survival Scores: PO2425

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.737-737

2020

Volltextzugriff (PDF)

Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome

Canadian journal of cardiology, 2016-10, Vol.32 (10), p.S349-S357

2016

Volltextzugriff (PDF)

meaRtools: An R package for the analysis of neuronal networks recorded on microelectrode arrays

PLoS computational biology, 2018-10, Vol.14 (10), p.e1006506-e1006506

2018

Volltextzugriff (PDF)

Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records

Clinical transplantation, 2024-04, Vol.38 (4), p.e15257-n/a

2024

Volltextzugriff (PDF)

CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update

Journal of rheumatology, 2021-04, Vol.48 (4), p.555-566

2021

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(91)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(32)
Humans
(21)
Female
(18)
Male
(16)
Biological And Medical Sciences
(15)
Fundamental And Applied Biological Sciences. Psychology
(12)
Adult
(11)
Animals
(11)
Middle Aged
(10)
Physical Sciences
(10)
Aged
(6)
Chemistry
(6)
Science & Technology - Other Topics
(6)
Mice
(5)
Benzopyran Derivatives
(4)
Control
(4)
Medical Sciences
(4)
Multidisciplinary Sciences
(4)
Physics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Highly enhanced Raman scattering from coupled vertical silicon nanowire arrays

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy

Nanowire dopant measurement using secondary ion mass spectrometry

PD-023 Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

PD-023Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) plus or minus 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

PD-023Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

Abstract P4-12-29: Assessment of safety and activity in an expanded phase 1 study of MM-302, a HER2-targeted liposomal doxorubicin, in patients with advanced HER2-positive (HER2+) breast cancer

A randomized, double-blind phase II trial of exemestane with or without MM-121 in postmenopausal women with locally advanced or metastatic estrogen receptor-positive (ER+) and/or progesterone receptor-positive (PR+), HER2-negative breast cancer

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency

Caffeine Effects on eGFR Dip in Patients Who Started SGLT2 Inhibitors: TH-PO1055

Rare variant associations with plasma protein levels in the UK Biobank

Epilepsy in a mouse model of GNB1 encephalopathy arises from altered potassium (GIRK) channel signaling and is alleviated by a GIRK inhibitor

Associations of Social Determinants of Health With SGLT2 Inhibitor Use in Kidney Transplant Recipients: A National Study: FR-PO814

Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences

Natural Approaches in Diabetes Management: A Review of Diet, Exercise, and Natural Products

Very Early Administration of Progesterone for Acute Traumatic Brain Injury

Arterial stiffening following eccentric exercise-induced muscle damage

Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity

Composite Events Associated with Increased Expected Post-Transplant Survival Scores: PO2425

Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome

meaRtools: An R package for the analysis of neuronal networks recorded on microelectrode arrays

Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records

CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update

Suchergebnisse filtern